#Ireland #Dublin #E-Commerce #Consumer Health #Perrigo

Perrigo to Participate in Oppenheimer 25th Annual Conference

Perrigo Company plc, a renowned leader in consumer self-care solutions, has made a notable announcement regarding its participation in the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference. The event is set to be conducted virtually on June 10, 2025, and will feature key insights from President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra. The presentation is scheduled for 9 AM ET.

Accessing the Conference

For those interested in learning more about Perrigo's strategic vision and updates, a live webcast of the presentation will be available through the Perrigo website at Perrigo Investor Events. Participants can expect an engaging discussion on consumer trends and how Perrigo continues to innovate in the self-care sector.

About Perrigo

Founded over a century ago, Perrigo Company plc has evolved into a prominent pure-play self-care entity specializing in health and wellness products. Based in Dublin, the company's extensive portfolio includes a variety of over-the-counter (OTC) solutions, allowing consumers to choose from a diverse range of accessible and effective health products without needing prescriptions.

As an industry pioneer, Perrigo has established a reputation built on quality and trust. The company's innovative approach integrates cash-generating store-brand private label offerings that support its well-known brands such as Opill®, Mederma®, Compeed®, EllaOne®, and Solpadeine®.

A Customer-Centric Focus

Perrigo's business strategy is centered around customer needs, with a commitment to providing reliable self-care products across various dosage forms and value tiers. This focus not only empowers consumers to manage their health effectively but also reflects Perrigo's dedication to affordability and accessibility in health solutions.

Looking Ahead

During the Oppenheimer conference, attendees can expect to hear about future trends in consumer healthcare and the evolving landscape of e-commerce which reshapes how consumers interact with health brands. Perrigo will likely discuss not only its current performance but also share insights into strategic initiatives aimed at growth in a competitive environment.

The company's focus remains on leveraging its unique business model to foster both innovation and development across its brand portfolio. Moreover, with significant attention to environmental, social, and governance aspects, Perrigo is poised to address emerging consumer preferences and expectations.

Investor Communication

Perrigo also encourages interested individuals, analysts, and investors to stay informed about the company’s performance by reviewing its filings with the United States Securities and Exchange Commission (SEC). The filings detail the company’s business condition, financial health, current risks, and potential opportunities.

For further inquiries regarding Perrigo’s investor relations, please contact:

• - Bradley Joseph, Vice President, Global Investor Relations at (269) 686-3373
• - Nicholas Gallagher, Senior Manager, Global Investor Relations at (269) 686-3238

In conclusion, Perrigo's participation in the Oppenheimer conference aligns with its ongoing efforts to maintain transparency and engage with stakeholders about its contributions to the consumer self-care market. The event promises to illuminate the company's forward-looking strategies and commitment to enhancing consumer health across various demographics.